Q2 FY2026 EarningsQ2 FY26 outperformed consensus expectations on the top line, with revenue of $22.4M exceeding the $16.8M forecast by 33%. While clinical diagnostic revenue surged 442% YoY, the company reported a larger-than-expected net loss of $31.7M ($0.30 per share) vs. the $27.6M loss anticipated, driven by significant increases in R&D and SG&A expenses. Following the merger agreement with Tempus AI, the company has suspended future financial guidance.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Personalis(PSNL) the Revenue is 22.36 M (+29.96%), Beat estimate;the EBIT is -33.59 M (-54.06%), Miss estimate;the EPS is -0.3 (-30.43%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.02B29.96%
0.02B2.40%
+0.01B32.36%
EBITMiss expectations
-0.03B54.06%
-0.03B35.98%
-0.00B18.08%
EPSMiss expectations
-0.330.43%
-0.271418.01%
-0.028612.42%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf